Optigenex expands Promethean partnership
This article was originally published in The Tan Sheet
Executive SummaryPromethean Corp. plans to expand its products into new markets under a renewed alliance with Optigenex Inc., which supplies the AC-11 ingredient to Promethean. The expanded licensing rights agreement announced Aug. 17 allows Promethean subsidiary Ceres Living to promote its skin care products and AIO Premium Cellular Health dietary supplements containing AC-11 worldwide, except in Japan and Turkey. Optigenex CEO Daniel Zwiren said the firms wanted "to expand our interactions into something more akin to a product development and marketing partnership than a supplier-customer relationship." The ingredient supplier claims AC-11 is the only product to repair DNA at the cellular level both systemically and topically (1"The Tan Sheet" April 5, 2010)
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).